Table 1 Epidemiologic and clinical characteristics of patients pulmonary nocardiosis, according to eGFR (n = 56)
From: Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis
|  | eGFR > 45 | eGFR ≤45 | p value |
|---|---|---|---|
n | 42 | 14 | Â |
Age (years) a | 67.4 ± 2.5 | 67.7 ± 2.9 | 0.55 |
Gender (Male/Female) | 21/21 | 6/8 | 0.64 |
BMI (kg/m2) a | 22.2 ± 0.7 | 22.2 ± 1.7 | 0.53 |
Diagnosis | |||
 Clinical | 24 (57.1%) | 7 (50.0%) | 0.64 |
 Histological | 10 (23.8%) | 2 (14.3%) | 0.44 |
 Pathogenic | 10 (23.8%) | 7 (50.0%) | 0.07 |
 Disseminated cryptococcosis | 1 (2.4%) | 3 (21.4%) | 0.03 |
Comorbidity | |||
 Pulmonary diseases | 4 (9.5%) | 1 (7.1%) | 0.78 |
 Diabetes mellitus | 12 (28.6%) | 6 (42.9%) | 0.33 |
 Connective tissue diseases | 4 (9.5%) | 2 (14.3%) | 0.63 |
 Malignancy | 12 (28.6%) | 2 (14.3%) | 0.26 |
 Immunosuppressive drug use | 14 (33.3%) | 9 (64.3%) | 0.04 |
 On hemodialysis | 0 (0.0%) | 1 (7.1%) | 0.09 |